MetaADEDB 2.0 @ LMMD
Exenatide
(HTQBXNHDCUEHJF-XWLPCZSASA-N)
Structure
SMILES
NCCCC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N)CO)C)CO)CO)CC(=O)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1nc[nH]c1)N)CCC(=O)O)Cc1ccccc1)CO)CC(=O)O)CC(C)C)CO)CCCCN)CCC(=O)N)CCSC)CCC(=O)O)CCC(=O)O)CCC(=O)O)C)CCCNC(=N)N)CC(C)C)Cc1ccccc1)CCC(=O)O)CC(C)C
Molecular Formula:
C184H282N50O60S
Molecular Weight:
4186.570
Log P:
-2.1694
Hydrogen Bond Acceptor:
109
Hydrogen Bond Donor:
58
TPSA:
1775.05
CAS Number(s):
141758-74-9
Synonym(s)
1.
Exenatide
2.
AC 2993
3.
AC 2993 LAR
4.
Bydureon
5.
Byetta
6.
Ex4 Peptide
7.
Exendin 4
8.
Exendin-4
9.
ITCA 650
10.
Peptide, Ex4
External Link(s)
MeSHD000077270
PubChem Compound56947125
91935542
45588096
16157882
BindingDB50241203
CHEMBLCHEMBL414357
DrugCentral1123
Therapeutic Target DatabaseD00YVF
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Blood glucose increasedFAERS: 3617
Canada Vigilance: 1
Canada Vigilance
US FAERS
2Weight decreasedFAERS: 3229SIDER
US FAERS
3NauseaFAERS: 2519
Canada Vigilance: 2
19171732CTD
SIDER
Canada Vigilance
US FAERS
4PancreatitisFAERS: 1434US FAERS
5Injection site painFAERS: 1233
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
6VomitingFAERS: 983
Canada Vigilance: 1
19171732CTD
SIDER
Canada Vigilance
US FAERS
7Injection site noduleFAERS: 832
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
8Product quality issueFAERS: 805US FAERS
9Injection site massFAERS: 663
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
10Blood glucose decreasedFAERS: 661SIDER
US FAERS
11MalaiseFAERS: 604US FAERS
12Injection site bruisingFAERS: 602US FAERS
13Incorrect dose administeredFAERS: 555US FAERS
14Drug dose omissionFAERS: 554US FAERS
15Injection site extravasationFAERS: 514
Canada Vigilance: 1
Canada Vigilance
US FAERS
16Injection site pruritusFAERS: 473
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
17Drug ineffectiveFAERS: 446
Canada Vigilance: 1
Canada Vigilance
US FAERS
18Pancreatic carcinomaFAERS: 420US FAERS
19Device malfunctionFAERS: 403
Canada Vigilance: 1
Canada Vigilance
US FAERS
20DizzinessFAERS: 402SIDER
US FAERS
21Feeling abnormalFAERS: 392US FAERS
22HeadacheFAERS: 362SIDER
US FAERS
23Injection site erythemaFAERS: 362
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
24Blood glucose abnormalFAERS: 307US FAERS
25Intentional product misuseFAERS: 298US FAERS
26FatigueFAERS: 287
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
27Medication ErrorFAERS: 283US FAERS
28Abdominal PainFAERS: 247SIDER
US FAERS
29ConstipationFAERS: 230SIDER
US FAERS
30AstheniaFAERS: 216SIDER
US FAERS
31Circumstance or information capable of leading to medication errorFAERS: 211US FAERS
32UrticariaFAERS: 192
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
33Wrong technique in product usage processFAERS: 183US FAERS
34DyspepsiaFAERS: 182SIDER
US FAERS
35Blood glucose fluctuationFAERS: 171US FAERS
36Needle issueFAERS: 171US FAERS
37PruritusFAERS: 170SIDER
US FAERS
38Injection site irritationFAERS: 167US FAERS
39TremorFAERS: 165
Canada Vigilance: 1
Canada Vigilance
US FAERS
40PainFAERS: 164US FAERS
41Injection site urticariaFAERS: 161US FAERS
42Wrong technique in device usage processFAERS: 146
Canada Vigilance: 1
Canada Vigilance
US FAERS
43Device leakageFAERS: 142US FAERS
44Injection Site ReactionFAERS: 142SIDER
US FAERS
45Abdominal discomfortFAERS: 141SIDER
US FAERS
46Intentional device misuseFAERS: 138US FAERS
47AnorexiaFAERS: 136SIDER
US FAERS
48NoduleFAERS: 133
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
49NasopharyngitisFAERS: 129SIDER
US FAERS
50Drug administration errorFAERS: 119US FAERS
51EructationFAERS: 114SIDER
US FAERS
52Accidental needle stickFAERS: 105US FAERS
53Diabetes mellitus inadequate controlFAERS: 104US FAERS
54Early satietyFAERS: 99US FAERS
55Feeling jitteryFAERS: 99SIDER
US FAERS
56Product use issueFAERS: 99US FAERS
57Accidental overdoseFAERS: 97US FAERS
58HypersensitivityFAERS: 97SIDER
US FAERS
59DehydrationFAERS: 94
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
60NervousnessFAERS: 94SIDER
US FAERS
61Back PainFAERS: 92SIDER
US FAERS
62DysgeusiaFAERS: 91SIDER
US FAERS
63FlatulenceFAERS: 90SIDER
US FAERS
64ChillsFAERS: 88SIDER
US FAERS
65SomnolenceFAERS: 87SIDER
US FAERS
66Drug ineffective for unapproved indicationFAERS: 86US FAERS
67Therapeutic response unexpectedFAERS: 86US FAERS
68Chest PainFAERS: 84SIDER
US FAERS
69HungerFAERS: 82US FAERS
70Adverse eventFAERS: 80US FAERS
71CholelithiasisFAERS: 80US FAERS
72InfluenzaFAERS: 80SIDER
US FAERS
73AlopeciaFAERS: 76SIDER
US FAERS
74Myocardial InfarctionFAERS: 74US FAERS
75Lipase increasedFAERS: 70US FAERS
76AnxietyFAERS: 69
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
77Visual ImpairmentFAERS: 67US FAERS
78PneumoniaFAERS: 63US FAERS
79Cerebrovascular accidentFAERS: 61US FAERS
80Drug prescribing errorFAERS: 60US FAERS
81Unevaluable eventFAERS: 59US FAERS
82ErythemaFAERS: 58SIDER
US FAERS
83PalpitationsFAERS: 58US FAERS
84Feeling ColdFAERS: 57US FAERS
85Product dose omissionFAERS: 57US FAERS
86Injection site injuryFAERS: 56US FAERS
87Memory impairmentFAERS: 55US FAERS
88ArthralgiaFAERS: 54SIDER
US FAERS
89Drug dispensing errorFAERS: 54US FAERS
90Impaired gastric emptyingFAERS: 54US FAERS
91Incorrect dose administered by deviceFAERS: 52US FAERS
92OverdoseFAERS: 49US FAERS
93SyncopeFAERS: 49US FAERS
94ArthritisFAERS: 48US FAERS
95Incorrect product storageFAERS: 48US FAERS
96Injury associated with deviceFAERS: 48US FAERS
97Pharmaceutical product complaintFAERS: 48US FAERS
98Wrong technique in drug usage processFAERS: 48US FAERS
99Injection site discomfortFAERS: 47US FAERS
100Device FailureFAERS: 46US FAERS
101Urinary tract infectionFAERS: 46SIDER
US FAERS
102Product use in unapproved indicationFAERS: 45US FAERS
103Injection site warmthFAERS: 44US FAERS
104CataractFAERS: 42US FAERS
105StressFAERS: 42
Canada Vigilance: 1
Canada Vigilance
US FAERS
106SwellingFAERS: 41US FAERS
107MyalgiaFAERS: 39US FAERS
108Burning sensationFAERS: 38US FAERS
109Blood triglycerides increasedFAERS: 37US FAERS
110NephrolithiasisFAERS: 37US FAERS
111SinusitisFAERS: 35SIDER
US FAERS
112Chest discomfortFAERS: 34US FAERS
113Blood creatinine increasedFAERS: 33SIDER
US FAERS
114Product packaging quantity issueFAERS: 33US FAERS
115CellulitisFAERS: 32US FAERS
116Device defectiveFAERS: 32US FAERS
117DysphoniaFAERS: 32US FAERS
118LethargyFAERS: 32US FAERS
119RetchingFAERS: 32US FAERS
120Oropharyngeal painFAERS: 29SIDER
US FAERS
121Visual disturbanceFAERS: 29US FAERS
122AngioedemaFAERS: 28SIDER
US FAERS
123Blood amylase increasedFAERS: 28US FAERS
124FlushingFAERS: 28US FAERS
125Injection site inflammationFAERS: 28US FAERS
126Depressed moodFAERS: 27US FAERS
127HypotensionFAERS: 27US FAERS
128VertigoFAERS: 27US FAERS
129Lip swellingFAERS: 26US FAERS
130Atrial FibrillationFAERS: 25US FAERS
131BronchitisFAERS: 25US FAERS
132Cold sweatFAERS: 24US FAERS
133Inappropriate schedule of drug administrationFAERS: 24US FAERS
134Injection site abscessFAERS: 24US FAERS
135Device difficult to useFAERS: 23US FAERS
136DiscomfortFAERS: 23US FAERS
137HypophagiaFAERS: 23US FAERS
138Product solubility abnormalFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
139Expired product administeredFAERS: 22US FAERS
140HyperchlorhydriaFAERS: 22US FAERS
141Pulmonary EmbolismFAERS: 22US FAERS
142Diabetic KetoacidosisFAERS: 21US FAERS
143DisorientationFAERS: 21US FAERS
144Drug exposure during pregnancyFAERS: 21US FAERS
145Peripheral swellingFAERS: 21US FAERS
146jaundiceFAERS: 21US FAERS
147CystitisFAERS: 20US FAERS
148DiverticulitisFAERS: 20US FAERS
149Food cravingFAERS: 20US FAERS
150General physical health deteriorationFAERS: 20US FAERS
151SepsisFAERS: 20US FAERS
152AmnesiaFAERS: 19US FAERS
153BlindnessFAERS: 19US FAERS
154No adverse eventFAERS: 19US FAERS
155TachycardiaFAERS: 1918420740CTD
SIDER
US FAERS
156ArthropathyFAERS: 18US FAERS
157Frustration tolerance decreasedFAERS: 18US FAERS
158HypersomniaFAERS: 18US FAERS
159Injection site scarFAERS: 18US FAERS
160Intentional product use issueFAERS: 18US FAERS
161CholecystitisFAERS: 17US FAERS
162InfectionFAERS: 17SIDER
US FAERS
163Intentional drug misuseFAERS: 17US FAERS
164Joint swellingFAERS: 17US FAERS
165Limb injuryFAERS: 17US FAERS
166Musculoskeletal PainFAERS: 17SIDER
US FAERS
167ThrombosisFAERS: 17US FAERS
168Acute kidney injuryFAERS: 16US FAERS
169Anaphylactic shockFAERS: 16SIDER
US FAERS
170Cardiac ArrestFAERS: 16US FAERS
171Diabetes MellitusFAERS: 16SIDER
US FAERS
172EpistaxisFAERS: 16US FAERS
173GoutFAERS: 16US FAERS
174Injection site vesiclesFAERS: 16US FAERS
175Intestinal ObstructionFAERS: 16US FAERS
176PresyncopeFAERS: 16US FAERS
177Device use issueFAERS: 15US FAERS
178HepatitisFAERS: 15US FAERS
179Pancreatic CystFAERS: 15US FAERS
180Pancreatic enzymes increasedFAERS: 15US FAERS
181Pharyngolaryngeal PainFAERS: 15US FAERS
182Therapy cessationFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
183ChromaturiaFAERS: 14US FAERS
184Dry skinFAERS: 14US FAERS
185Infrequent bowel movementsFAERS: 14US FAERS
186Injection site hypersensitivityFAERS: 14US FAERS
187Injection site infectionFAERS: 14US FAERS
188SluggishnessFAERS: 14US FAERS
189ThirstFAERS: 14US FAERS
190Angina PectorisFAERS: 13US FAERS
191AsthmaFAERS: 13US FAERS
192ColitisFAERS: 13US FAERS
193Food aversionFAERS: 13US FAERS
194GastritisFAERS: 13US FAERS
195Injection site coldnessFAERS: 13US FAERS
196Musculoskeletal chest painFAERS: 13US FAERS
197Neck PainFAERS: 13US FAERS
198ShockFAERS: 13US FAERS
199Bowel movement irregularityFAERS: 12US FAERS
200Incorrect route of drug administrationFAERS: 12US FAERS
201ToothacheFAERS: 12SIDER
US FAERS
202AgeusiaFAERS: 11US FAERS
203AgitationFAERS: 11US FAERS
204AngerFAERS: 11US FAERS
205Blood cholesterol increasedFAERS: 11US FAERS
206Deep Vein ThrombosisFAERS: 11US FAERS
207Device use errorFAERS: 11US FAERS
208DysuriaFAERS: 11US FAERS
209HerniaFAERS: 11US FAERS
210Respiratory FailureFAERS: 11US FAERS
211Skin reactionFAERS: 11US FAERS
212Throat irritationFAERS: 11US FAERS
213Acute myocardial infarctionFAERS: 10US FAERS
214Ankle FractureFAERS: 10US FAERS
215Circumstance or information capable of leading to device use errorFAERS: 10US FAERS
216DeafnessFAERS: 10US FAERS
217Flank PainFAERS: 10US FAERS
218Injection site cellulitisFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
219LymphomaFAERS: 10US FAERS
220Musculoskeletal stiffnessFAERS: 10US FAERS
221Product storage errorFAERS: 10US FAERS
222Rash erythematousFAERS: 10US FAERS
223Renal painFAERS: 10US FAERS
224SneezingFAERS: 10US FAERS
225TinnitusFAERS: 10US FAERS
226Accidental exposure to productFAERS: 9US FAERS
227AppendicitisFAERS: 9US FAERS
228Back disorderFAERS: 9US FAERS
229CystFAERS: 9US FAERS
230Depressed Level of ConsciousnessFAERS: 9US FAERS
231Drug effect incompleteFAERS: 9US FAERS
232Extra dose administeredFAERS: 9US FAERS
233Eye irritationFAERS: 9US FAERS
234Gastric BypassFAERS: 9US FAERS
235GastroenteritisFAERS: 9SIDER
US FAERS
236Gastrointestinal PainFAERS: 9SIDER
US FAERS
237Injection site cystFAERS: 9US FAERS
238Liquid product physical issueFAERS: 9US FAERS
239LymphadenopathyFAERS: 9US FAERS
240Musculoskeletal discomfortFAERS: 9SIDER
US FAERS
241ObesityFAERS: 9US FAERS
242OverweightFAERS: 9US FAERS
243Pancreatic NeoplasmFAERS: 9US FAERS
244Product compounding quality issueFAERS: 9US FAERS
245Rheumatoid ArthritisFAERS: 9US FAERS
246Urinary IncontinenceFAERS: 9US FAERS
247AphoniaFAERS: 8US FAERS
248Blood urine presentFAERS: 8US FAERS
249CryingFAERS: 8US FAERS
250Erectile dysfunctionFAERS: 8SIDER
US FAERS
251Expired drug administeredFAERS: 8US FAERS
252Food PoisoningFAERS: 8US FAERS
253Gamma-Glutamyltransferase IncreasedFAERS: 8US FAERS
254IleusFAERS: 8SIDER
US FAERS
255Incorrect disposal of productFAERS: 8US FAERS
256InflammationFAERS: 824534256CTD
US FAERS
257Injection site scabFAERS: 8US FAERS
258Irritable Bowel SyndromeFAERS: 8US FAERS
259LaryngitisFAERS: 8US FAERS
260Ligament ruptureFAERS: 8US FAERS
261Macular degenerationFAERS: 8US FAERS
262MenorrhagiaFAERS: 8US FAERS
263Product leakageFAERS: 8US FAERS
264Product preparation errorFAERS: 8US FAERS
265Skin irritationFAERS: 8US FAERS
266Thyroid NeoplasmFAERS: 8US FAERS
267TrichorrhexisFAERS: 8US FAERS
268UlcerFAERS: 8US FAERS
269WheezingFAERS: 8US FAERS
270Alanine Aminotransferase IncreasedFAERS: 7US FAERS
271Foreign body traumaFAERS: 7US FAERS
272Head discomfortFAERS: 7US FAERS
273Insurance issueFAERS: 7US FAERS
274Joint injuryFAERS: 7US FAERS
275Mental impairmentFAERS: 7US FAERS
276Mood swingsFAERS: 7US FAERS
277PhotophobiaFAERS: 7US FAERS
278Rotator cuff syndromeFAERS: 7US FAERS
279Sinus headacheFAERS: 7US FAERS
280Skin UlcerFAERS: 7US FAERS
281Skin lesionFAERS: 7US FAERS
282Sudden deathFAERS: 7US FAERS
283Umbilical herniaFAERS: 7US FAERS
284AbasiaFAERS: 6US FAERS
285AcneFAERS: 6US FAERS
286Aspartate Aminotransferase IncreasedFAERS: 6US FAERS
287Blood magnesium decreasedFAERS: 6US FAERS
288Blood potassium increasedFAERS: 6US FAERS
289Blood urea increasedFAERS: 6US FAERS
290DiplopiaFAERS: 6US FAERS
291EczemaFAERS: 6US FAERS
292Eye painFAERS: 6US FAERS
293Hip surgeryFAERS: 6US FAERS
294InfarctionFAERS: 6US FAERS
295LeukocytosisFAERS: 6US FAERS
296Limb discomfortFAERS: 6US FAERS
297Night sweatsFAERS: 6US FAERS
298No adverse effectFAERS: 6US FAERS
299Non-cardiac chest painFAERS: 6US FAERS
300PallorFAERS: 6US FAERS
301Pancreatic PseudocystFAERS: 6US FAERS
302Pericardial effusionFAERS: 6US FAERS
303PregnancyFAERS: 6US FAERS
304StomatitisFAERS: 6US FAERS
305VasculitisFAERS: 6US FAERS
306Activities of daily living impairedFAERS: 5US FAERS
307Amylase increasedFAERS: 5US FAERS
308ArteriosclerosisFAERS: 5US FAERS
309Arthropod biteFAERS: 5US FAERS
310Benign neoplasm of thyroid glandFAERS: 5US FAERS
311Blood pressure fluctuationFAERS: 5US FAERS
312Cataract operationFAERS: 5US FAERS
313FibromyalgiaFAERS: 5US FAERS
314FormicationFAERS: 5US FAERS
315Gastric ulcerFAERS: 5US FAERS
316Gastrointestinal infectionFAERS: 5US FAERS
317GlaucomaFAERS: 5US FAERS
318HyperphagiaFAERS: 5US FAERS
319HyperthyroidismFAERS: 5US FAERS
320HypothyroidismFAERS: 5US FAERS
321HypotrichosisFAERS: 5US FAERS
322Injection site pustuleFAERS: 5US FAERS
323KetoacidosisFAERS: 5US FAERS
324Limb massFAERS: 5US FAERS
325Lipodystrophy acquiredFAERS: 5US FAERS
326LipomaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
327Maternal exposure during pregnancyFAERS: 5US FAERS
328Medical device complicationFAERS: 5US FAERS
329Multi-organ disorderFAERS: 5US FAERS
330NeuropathyFAERS: 5US FAERS
331Paranasal sinus hypersecretionFAERS: 5US FAERS
332PolyuriaFAERS: 5US FAERS
333Post procedural complicationFAERS: 5US FAERS
334Product label issueFAERS: 5US FAERS
335Product physical issueFAERS: 5US FAERS
336Product preparation issueFAERS: 5US FAERS
337Product quality control issueFAERS: 5US FAERS
338Product substitution issueFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
339Protein urine presentFAERS: 5US FAERS
340Retinal DetachmentFAERS: 5US FAERS
341RhabdomyolysisFAERS: 5US FAERS
342Skin lacerationFAERS: 5US FAERS
343Spinal fusion surgeryFAERS: 5US FAERS
344Sudden Cardiac DeathFAERS: 5US FAERS
345Suicide attemptFAERS: 5US FAERS
346Syringe issueFAERS: 5US FAERS
347Transaminases increasedFAERS: 5US FAERS
348VIIth nerve paralysisFAERS: 5US FAERS
349Abdominal massFAERS: 4US FAERS
350Abdominal rigidityFAERS: 4US FAERS
351Accidental exposureFAERS: 4US FAERS
352Aortic AneurysmFAERS: 4US FAERS
353AphagiaFAERS: 4US FAERS
354AscitesFAERS: 4US FAERS
355Auricular swellingFAERS: 4US FAERS
356Blood GlucoseFAERS: 4US FAERS
357Blood creatine increasedFAERS: 4US FAERS
358Carpal Tunnel SyndromeFAERS: 4US FAERS
359ChokingFAERS: 4US FAERS
360Coronary Artery DiseaseFAERS: 4US FAERS
361DementiaFAERS: 4US FAERS
362DermatitisFAERS: 4US FAERS
363Device occlusionFAERS: 4US FAERS
364Drug dose omission by deviceFAERS: 4US FAERS
365Drug effect delayedFAERS: 4US FAERS
366Emotional distressFAERS: 4US FAERS
367EosinophiliaFAERS: 4US FAERS
368Eye InfectionFAERS: 4US FAERS
369Gastrointestinal sounds abnormalFAERS: 4US FAERS
370GlossitisFAERS: 4US FAERS
371Guillain-Barre SyndromeFAERS: 4US FAERS
372Impaired work abilityFAERS: 4US FAERS
373Increased tendency to bruiseFAERS: 4US FAERS
374Increased upper airway secretionFAERS: 4US FAERS
375Injection site dischargeFAERS: 4US FAERS
376Injection site lacerationFAERS: 4US FAERS
377Injection site ulcerFAERS: 4US FAERS
378Intentional device use issueFAERS: 4US FAERS
379LacerationFAERS: 4US FAERS
380Metastatic NeoplasmFAERS: 4US FAERS
381MetrorrhagiaFAERS: 4US FAERS
382Motion SicknessFAERS: 4US FAERS
383Multiple allergiesFAERS: 4US FAERS
384Oropharyngeal discomfortFAERS: 4US FAERS
385Pancreatic Duct StenosisFAERS: 4US FAERS
386Pancreatic InsufficiencyFAERS: 4US FAERS
387Panic DisorderFAERS: 4US FAERS
388PeritonitisFAERS: 4US FAERS
389Post procedural infectionFAERS: 4US FAERS
390Productive CoughFAERS: 4US FAERS
391PsoriasisFAERS: 4US FAERS
392RegurgitationFAERS: 4US FAERS
393Renal Cell CarcinomaFAERS: 4US FAERS
394Renal cystFAERS: 4US FAERS
395Respiratory arrestFAERS: 4US FAERS
396Skin WrinklingFAERS: 4US FAERS
397Uterine CancerFAERS: 4US FAERS
398Vitreous floatersFAERS: 4US FAERS
399Waist circumference increasedFAERS: 4US FAERS
400furuncleFAERS: 4US FAERS
401nervous system disorderFAERS: 4SIDER
US FAERS
402Abdominal AbscessFAERS: 3US FAERS
403Abdominal tendernessFAERS: 3US FAERS
404AbscessFAERS: 3US FAERS
405Acanthosis NigricansFAERS: 3US FAERS
406AcidosisFAERS: 3US FAERS
407Altered state of consciousnessFAERS: 3US FAERS
408AneurysmFAERS: 3US FAERS
409Antiviral drug level below therapeuticFAERS: 3US FAERS
410Aortic Valve StenosisFAERS: 3US FAERS
411AphasiaFAERS: 3US FAERS
412Aphthous StomatitisFAERS: 3US FAERS
413Arthropod stingFAERS: 3US FAERS
414Atrial FlutterFAERS: 3US FAERS
415Benign Prostatic HyperplasiaFAERS: 3US FAERS
416Biliary DyskinesiaFAERS: 3US FAERS
417Blood alkaline phosphatase increasedFAERS: 3US FAERS
418Blood calcitonin increasedFAERS: 3US FAERS
419Blood cholesterol abnormalFAERS: 3US FAERS
420Blood count abnormalFAERS: 3US FAERS
421Blood sodium decreasedFAERS: 3US FAERS
422Blood triglycerides abnormalFAERS: 3US FAERS
423BradycardiaFAERS: 3US FAERS
424Cardiac discomfortFAERS: 3US FAERS
425Cerebral InfarctionFAERS: 3US FAERS
426CholangitisFAERS: 3US FAERS
427Complication associated with deviceFAERS: 3US FAERS
428Creatinine renal clearance increasedFAERS: 3US FAERS
429Dandy-Walker SyndromeFAERS: 3US FAERS
430Device related infectionFAERS: 3US FAERS
431Diabetic FootFAERS: 3US FAERS
432Disease complicationFAERS: 3US FAERS
433Disease recurrenceFAERS: 3US FAERS
434DysarthriaFAERS: 3US FAERS
435Ear discomfortFAERS: 3US FAERS
436Emotional disorderFAERS: 3US FAERS
437ErysipelasFAERS: 3US FAERS
438ExcoriationFAERS: 3US FAERS
439Gallbladder painFAERS: 3US FAERS
440Gastrointestinal motility disorderFAERS: 3US FAERS
441HemiplegiaFAERS: 3US FAERS
442HepatomegalyFAERS: 3US FAERS
443Hormone level abnormalFAERS: 3US FAERS
444HypogeusiaFAERS: 3US FAERS
445ImmobileFAERS: 3US FAERS
446Impaired driving abilityFAERS: 3US FAERS
447Incision site infectionFAERS: 3US FAERS
448Incorrect drug administration durationFAERS: 3US FAERS
449IndurationFAERS: 3SIDER
US FAERS
450Initial insomniaFAERS: 3US FAERS
451Injection site indentationFAERS: 3US FAERS
452InjectionFAERS: 3US FAERS
453Intercepted medication errorFAERS: 3US FAERS
454Intervertebral Disc DegenerationFAERS: 3US FAERS
455Lower respiratory tract infectionFAERS: 3US FAERS
456MalabsorptionFAERS: 3US FAERS
457Metabolic acidosisFAERS: 3US FAERS
458Multiple use of single-use productFAERS: 3US FAERS
459Muscle FatigueFAERS: 3US FAERS
460Muscle tightnessFAERS: 3US FAERS
461Nerve injuryFAERS: 3US FAERS
462Nonspecific reactionFAERS: 3US FAERS
463Obesity surgeryFAERS: 3US FAERS
464Ocular discomfortFAERS: 3US FAERS
465Off label use of deviceFAERS: 3US FAERS
466Oropharyngeal swellingFAERS: 3US FAERS
467Palmar erythemaFAERS: 3US FAERS
468Pancreatic enzymes abnormalFAERS: 3US FAERS
469Paranasal sinus discomfortFAERS: 3US FAERS
470Peripheral arterial occlusive diseaseFAERS: 3US FAERS
471PharyngitisFAERS: 3US FAERS
472PolydipsiaFAERS: 3US FAERS
473Poor quality drug administeredFAERS: 3US FAERS
474Pre-existing condition improvedFAERS: 3US FAERS
475Product packaging issueFAERS: 3US FAERS
476Product prescribing issueFAERS: 3US FAERS
477Product use complaintFAERS: 3US FAERS
478PseudocystFAERS: 3US FAERS
479Renal massFAERS: 3US FAERS
480Respiratory tract congestionFAERS: 3US FAERS
481RestlessnessFAERS: 3US FAERS
482SarcoidosisFAERS: 3US FAERS
483ScabFAERS: 3US FAERS
484SchizophreniaFAERS: 3US FAERS
485ScreamingFAERS: 3US FAERS
486Skin noduleFAERS: 3US FAERS
487SplenectomyFAERS: 3US FAERS
488StarvationFAERS: 3US FAERS
489Subcutaneous noduleFAERS: 3US FAERS
490Supraventricular tachycardiaFAERS: 3US FAERS
491Temperature intoleranceFAERS: 3US FAERS
492TensionFAERS: 3US FAERS
493Thirst decreasedFAERS: 3US FAERS
494Throat cancerFAERS: 3US FAERS
495Toxicity to various agentsFAERS: 3US FAERS
496Trisomy 21FAERS: 3US FAERS
497Unresponsive to stimuliFAERS: 3US FAERS
498Urinary RetentionFAERS: 3US FAERS
499Vascular occlusionFAERS: 3US FAERS
500Viral load increasedFAERS: 3US FAERS
501Walking aid userFAERS: 3US FAERS
502WeightFAERS: 3US FAERS
503muscle injuryFAERS: 3US FAERS
504Acute respiratory failureFAERS: 2US FAERS
505AdenocarcinomaFAERS: 2US FAERS
506Administration site noduleFAERS: 2US FAERS
507Adnexa uteri painFAERS: 2US FAERS
508AmputationFAERS: 2US FAERS
509Anorectal infectionFAERS: 2US FAERS
510Apparent deathFAERS: 2US FAERS
511Arteriovenous fistula aneurysmFAERS: 2US FAERS
512AsphyxiaFAERS: 2US FAERS
513AsthenopiaFAERS: 2US FAERS
514BedriddenFAERS: 2US FAERS
515Benign NeoplasmFAERS: 2US FAERS
516Blood blisterFAERS: 2US FAERS
517Blood chloride decreasedFAERS: 2US FAERS
518Blood creatine phosphokinase increasedFAERS: 2US FAERS
519Blood iron decreasedFAERS: 2US FAERS
520Blood potassium decreasedFAERS: 2US FAERS
521Blood sodium increasedFAERS: 2US FAERS
522Blood testosterone decreasedFAERS: 2US FAERS
523Body temperature fluctuationFAERS: 2US FAERS
524Breast cancer recurrentFAERS: 2US FAERS
525CalciphylaxisFAERS: 2US FAERS
526Cardiac FlutterFAERS: 2US FAERS
527CholangiocarcinomaFAERS: 2US FAERS
528Cholecystitis infectiveFAERS: 2US FAERS
529Clostridium difficile colitisFAERS: 2US FAERS
530Clostridium difficile infectionFAERS: 2US FAERS
531Completed SuicideFAERS: 2US FAERS
532ConjunctivitisFAERS: 2US FAERS
533DeliriumFAERS: 2US FAERS
534Device breakageFAERS: 2US FAERS
535Diabetic foot infectionFAERS: 2US FAERS
536DiplegiaFAERS: 2US FAERS
537DisabilityFAERS: 2US FAERS
538DiverticulumFAERS: 2US FAERS
539Drug ToleranceFAERS: 2US FAERS
540Drug administered at inappropriate siteFAERS: 2US FAERS
541Drug exposure before pregnancyFAERS: 2US FAERS
542DysphasiaFAERS: 2US FAERS
543EcchymosisFAERS: 2US FAERS
544Enzyme abnormalityFAERS: 2US FAERS
545EpicondylitisFAERS: 2US FAERS
546EpilepsyFAERS: 2US FAERS
547Exaggerated startle responseFAERS: 2US FAERS
548Excessive skinFAERS: 2US FAERS
549Extremity necrosisFAERS: 2US FAERS
550Eye inflammationFAERS: 2US FAERS
551Fat necrosisFAERS: 2US FAERS
552FibrosisFAERS: 2US FAERS
553Food AllergyFAERS: 2US FAERS
554FrustrationFAERS: 2US FAERS
555Gastric ileusFAERS: 2US FAERS
556Gastrointestinal carcinomaFAERS: 2US FAERS
557HemiparesisFAERS: 2US FAERS
558HepatotoxicityFAERS: 2US FAERS
559Hernia obstructiveFAERS: 2US FAERS
560HidradenitisFAERS: 2US FAERS
561HyperkeratosisFAERS: 2US FAERS
562HyperpyrexiaFAERS: 2US FAERS
563Hypertensive crisisFAERS: 2US FAERS
564HyperventilationFAERS: 2US FAERS
565HysterectomyFAERS: 2US FAERS
566Incorrect storage of drugFAERS: 2US FAERS
567Injection site joint erythemaFAERS: 2US FAERS
568Injection site necrosisFAERS: 2US FAERS
569Injection site papuleFAERS: 2US FAERS
570Injection site streakingFAERS: 2US FAERS
571Intercepted drug dispensing errorFAERS: 2US FAERS
572Intervertebral disc disorderFAERS: 2US FAERS
573Intestinal infarctionFAERS: 2US FAERS
574Keratoconjunctivitis SiccaFAERS: 2US FAERS
575KetosisFAERS: 2US FAERS
576Lack of satietyFAERS: 2US FAERS
577Lactose IntoleranceFAERS: 2US FAERS
578Leukocytoclastic vasculitisFAERS: 2US FAERS
579Ligament injuryFAERS: 2US FAERS
580Lipase abnormalFAERS: 2US FAERS
581LithotripsyFAERS: 2US FAERS
582MalnutritionFAERS: 2SIDER
US FAERS
583Maternal exposure timing unspecifiedFAERS: 2US FAERS
584MegacolonFAERS: 2US FAERS
585Mental status changesFAERS: 2US FAERS
586MicroalbuminuriaFAERS: 2US FAERS
587Middle insomniaFAERS: 2US FAERS
588Migraine with AuraFAERS: 2US FAERS
589Mixed liver injuryFAERS: 2US FAERS
590MonoparesisFAERS: 2US FAERS
591Muscle strainFAERS: 2US FAERS
592Nasal discomfortFAERS: 2US FAERS
593NephritisFAERS: 2US FAERS
594NeuralgiaFAERS: 2US FAERS
595NeutropeniaFAERS: 2US FAERS
596Nipple painFAERS: 2US FAERS
597NocturiaFAERS: 2US FAERS
598Ocular icterusFAERS: 2US FAERS
599OnychoclasisFAERS: 2US FAERS
600Optic NeuritisFAERS: 2US FAERS
601Oral candidiasisFAERS: 2US FAERS
602Oral fungal infectionFAERS: 2US FAERS
603Pancreatic carcinoma non-resectableFAERS: 2US FAERS
604PanniculitisFAERS: 2US FAERS
605ParanoiaFAERS: 2US FAERS
606PemphigusFAERS: 2US FAERS
607PericarditisFAERS: 2US FAERS
608Personality ChangeFAERS: 2US FAERS
609PolyneuropathyFAERS: 2US FAERS
610Poor peripheral circulationFAERS: 2US FAERS
611Post-Traumatic Stress DisorderFAERS: 2US FAERS
612Product administration errorFAERS: 2US FAERS
613Product contaminationFAERS: 2US FAERS
614Product label confusionFAERS: 2US FAERS
615Product physical consistency issueFAERS: 2US FAERS
616Pulmonary HypertensionFAERS: 2US FAERS
617Renal tubular necrosisFAERS: 2US FAERS
618Restless Legs SyndromeFAERS: 2US FAERS
619RosaceaFAERS: 2US FAERS
620SciaticaFAERS: 2US FAERS
621Secretion dischargeFAERS: 2US FAERS
622Sensitive skinFAERS: 2US FAERS
623Sexual DysfunctionFAERS: 2US FAERS
624Skeletal injuryFAERS: 2US FAERS
625Skin PapillomaFAERS: 2US FAERS
626Skin hypertrophyFAERS: 2US FAERS
627Skin necrosisFAERS: 2US FAERS
628Sleep disorder due to general medical condition, hypersomnia typeFAERS: 2US FAERS
629Spinal column stenosisFAERS: 2US FAERS
630SplenomegalyFAERS: 2US FAERS
631Stevens-Johnson SyndromeFAERS: 2US FAERS
632Synovial CystFAERS: 2US FAERS
633Therapeutic product contaminationFAERS: 2US FAERS
634Thermal burnFAERS: 2US FAERS
635Tooth LossFAERS: 2US FAERS
636Tracheal StenosisFAERS: 2US FAERS
637Upper-airway cough syndromeFAERS: 2US FAERS
638Urine flow decreasedFAERS: 2US FAERS
639Urine output increasedFAERS: 2US FAERS
640Urticaria localisedFAERS: 2US FAERS
641Vasculitic rashFAERS: 2US FAERS
642Ventricular FibrillationFAERS: 2US FAERS
643Vitreous DetachmentFAERS: 2US FAERS
644Vulvovaginal drynessFAERS: 2US FAERS
645White blood cell count decreasedFAERS: 2US FAERS
646Wound abscessFAERS: 2US FAERS
647Wrong drug administeredFAERS: 2US FAERS
648Accidental underdoseFAERS: 1US FAERS
649Acquired hydroceleFAERS: 1US FAERS
650Acute Coronary SyndromeFAERS: 1US FAERS
651Administration site bruiseFAERS: 1US FAERS
652Alcohol poisoningFAERS: 1US FAERS
653Alopecia AreataFAERS: 1US FAERS
654Amphetamines positiveFAERS: 1US FAERS
655Anaphylactoid ReactionFAERS: 1US FAERS
656Angle Closure GlaucomaFAERS: 1US FAERS
657Animal biteFAERS: 1US FAERS
658AnorgasmiaFAERS: 1US FAERS
659AnosmiaFAERS: 1US FAERS
660Anti-GAD antibody positiveFAERS: 1US FAERS
661Anticoagulation drug level below therapeuticFAERS: 1US FAERS
662AnuriaFAERS: 1US FAERS
663Aortic occlusionFAERS: 1US FAERS
664Apallic syndromeFAERS: 1US FAERS
665ApathyFAERS: 1US FAERS
666Application site warmthFAERS: 1US FAERS
667AtelectasisFAERS: 1US FAERS
668Atrioventricular BlockFAERS: 1US FAERS
669Autoimmune PancreatitisFAERS: 1US FAERS
670Bacteria urine identifiedFAERS: 1US FAERS
671Benign neoplasm of skinFAERS: 1US FAERS
672Biliary ColicFAERS: 1US FAERS
673Biliary cirrhosisFAERS: 1US FAERS
674Biliary dilatationFAERS: 1US FAERS
675Bilirubin conjugated increasedFAERS: 1US FAERS
676Bipolar DisorderFAERS: 1US FAERS
677Bladder NeoplasmFAERS: 1US FAERS
678Bladder painFAERS: 1US FAERS
679Blood alcohol increasedFAERS: 1US FAERS
680Blood amylase decreasedFAERS: 1US FAERS
681Blood bilirubin unconjugated increasedFAERS: 1US FAERS
682Blood catecholamines increasedFAERS: 1US FAERS
683Blood cortisol decreasedFAERS: 1US FAERS
684Blood electrolytes abnormalFAERS: 1US FAERS
685Blood insulin decreasedFAERS: 1US FAERS
686Blood ketone bodyFAERS: 1US FAERS
687Blood lactic acid abnormalFAERS: 1US FAERS
688Blood potassium abnormalFAERS: 1US FAERS
689Blood prolactin increasedFAERS: 1US FAERS
690Blood sodium abnormalFAERS: 1US FAERS
691Blood testosterone free decreasedFAERS: 1US FAERS
692Blood triglycerides decreasedFAERS: 1US FAERS
693Bone density decreasedFAERS: 1US FAERS
694BoredomFAERS: 1US FAERS
695Breast CystFAERS: 1US FAERS
696BronchopneumoniaFAERS: 1US FAERS
697Burn infectionFAERS: 1US FAERS
698Calcific deposits removalFAERS: 1US FAERS
699CalcinosisFAERS: 1US FAERS
700Carbohydrate antigen 19-9 increasedFAERS: 1US FAERS
701Carcinoembryonic antigen increasedFAERS: 1US FAERS
702Cardiac TamponadeFAERS: 1US FAERS
703Cardiac valve replacement complicationFAERS: 1US FAERS
704CardiomegalyFAERS: 1US FAERS
705Cartilage injuryFAERS: 1US FAERS
706Cataract operation complicationFAERS: 1US FAERS
707Cerebral ThrombosisFAERS: 1US FAERS
708Cerebral atrophyFAERS: 1US FAERS
709Cerebral disorderFAERS: 1US FAERS
710Cerebral ventricle dilatationFAERS: 1US FAERS
711CheilitisFAERS: 1US FAERS
712ChemotherapyFAERS: 1US FAERS
713CholecystostomyFAERS: 1US FAERS
714CholeraFAERS: 1US FAERS
715CholestasisFAERS: 1US FAERS
716ChromatopsiaFAERS: 1US FAERS
717Chronic gastritisFAERS: 1US FAERS
718Chronic sinusitisFAERS: 1US FAERS
719Coagulation time shortenedFAERS: 1US FAERS
720CoccidioidomycosisFAERS: 1US FAERS
721ColectomyFAERS: 1US FAERS
722Complication of device insertionFAERS: 1US FAERS
723Consciousness fluctuatingFAERS: 1US FAERS
724Conversion disorderFAERS: 1US FAERS
725Coronary artery reocclusionFAERS: 1US FAERS
726Cortisol increasedFAERS: 1US FAERS
727Creatinine renal clearance decreasedFAERS: 1US FAERS
728CyanosisFAERS: 1US FAERS
729CystoceleFAERS: 1US FAERS
730Deafness NeurosensoryFAERS: 1US FAERS
731Dental cariesFAERS: 1US FAERS
732Depression suicidalFAERS: 1US FAERS
733Dermatitis acneiformFAERS: 1US FAERS
734Device physical property issueFAERS: 1US FAERS
735Diabetic NephropathyFAERS: 1US FAERS
736Diabetic RetinopathyFAERS: 1US FAERS
737Disease ProgressionFAERS: 1US FAERS
738Disseminated Intravascular CoagulationFAERS: 1US FAERS
739DroolingFAERS: 1US FAERS
740Drug abuseFAERS: 1US FAERS
741Drug administered in wrong deviceFAERS: 1US FAERS
742Drug delivery system malfunctionFAERS: 1US FAERS
743Drug effect variableFAERS: 1US FAERS
744Drug exposure via breast milkFAERS: 1US FAERS
745Drug level above therapeuticFAERS: 1US FAERS
746Drug physiologic incompatibilityFAERS: 1US FAERS
747Drug screen positiveFAERS: 1US FAERS
748Drug specific antibody presentFAERS: 1US FAERS
749Drug toxicityFAERS: 1US FAERS
750Drug withdrawal syndromeFAERS: 1US FAERS
751DuodenitisFAERS: 1US FAERS
752DyscheziaFAERS: 1US FAERS
753DysplasiaFAERS: 1US FAERS
754Dyspnoea exacerbatedFAERS: 1US FAERS
755DystoniaFAERS: 1US FAERS
756Ear, nose and throat examination abnormalFAERS: 1US FAERS
757Ectopic PregnancyFAERS: 1US FAERS
758Educational problemFAERS: 1US FAERS
759Ejection fraction abnormalFAERS: 1US FAERS
760Electrolyte imbalanceFAERS: 1US FAERS
761EndometriosisFAERS: 1US FAERS
762EnteritisFAERS: 1US FAERS
763Enterococcal sepsisFAERS: 1US FAERS
764EnterocolitisFAERS: 1US FAERS
765Eosinophilic PneumoniaFAERS: 1US FAERS
766Eosinophilic granulomatosis with polyangiitisFAERS: 1US FAERS
767Eosinophilic panniculitisFAERS: 1US FAERS
768Epigastric discomfortFAERS: 1US FAERS
769Erythema InduratumFAERS: 1US FAERS
770Erythema NodosumFAERS: 1US FAERS
771Escherichia sepsisFAERS: 1US FAERS
772Euphoric moodFAERS: 1US FAERS
773Expired device usedFAERS: 1US FAERS
774Eye allergyFAERS: 1US FAERS
775Eye laser surgeryFAERS: 1US FAERS
776Eyelid Function DisorderFAERS: 1US FAERS
777Facial PainFAERS: 1US FAERS
778Failure to ThriveFAERS: 1US FAERS
779Fear of fallingFAERS: 1US FAERS
780Feeling of body temperature changeFAERS: 1US FAERS
781Flight of ideasFAERS: 1US FAERS
782Fluid imbalanceFAERS: 1US FAERS
783Foaming at mouthFAERS: 1US FAERS
784Foreign body sensation in eyesFAERS: 1US FAERS
785Full blood count decreasedFAERS: 1US FAERS
786Gastric DilatationFAERS: 1US FAERS
787Gastric hypermotilityFAERS: 1US FAERS
788Gastric hypomotilityFAERS: 1US FAERS
789Gastric mucosal lesionFAERS: 1US FAERS
790Gastrointestinal cancer metastaticFAERS: 1US FAERS
791Gastrointestinal candidiasisFAERS: 1US FAERS
792Gastrointestinal hypomotilityFAERS: 1US FAERS
793GastrolithiasisFAERS: 1US FAERS
794Gastrooesophageal cancerFAERS: 1US FAERS
795General physical condition abnormalFAERS: 1US FAERS
796General symptomFAERS: 1US FAERS
797Genital rashFAERS: 1US FAERS
798GingivitisFAERS: 1US FAERS
799GlomerulonephritisFAERS: 1US FAERS
800Helicobacter test positiveFAERS: 1US FAERS
801Hepatic EncephalopathyFAERS: 1US FAERS
802Hepatic cancer metastaticFAERS: 1US FAERS
803Hepatic cancer stage IVFAERS: 1US FAERS
804Hepatic necrosisFAERS: 1US FAERS
805Hepatobiliary scanFAERS: 1US FAERS
806HeteroplasiaFAERS: 1US FAERS
807HirsutismFAERS: 1US FAERS
808Histrionic Personality DisorderFAERS: 1US FAERS
809Humidity intoleranceFAERS: 1US FAERS
810HyperinsulinismFAERS: 1US FAERS
811HyperlipasaemiaFAERS: 1US FAERS
812HyperparathyroidismFAERS: 1US FAERS
813Hyperplastic cholecystopathyFAERS: 1US FAERS
814Hypertensive emergencyFAERS: 1US FAERS
815HypokinesiaFAERS: 1US FAERS
816Idiopathic neutropeniaFAERS: 1US FAERS
817Illogical thinkingFAERS: 1US FAERS
818Immune thrombocytopenic purpuraFAERS: 1US FAERS
819Immune-mediated adverse reactionFAERS: 1US FAERS
820Inability to afford medicationFAERS: 1US FAERS
821Inappropriate schedule of product administrationFAERS: 1US FAERS
822IncoherentFAERS: 1US FAERS
823IncontinenceFAERS: 1US FAERS
824Incorrect dose administered by productFAERS: 1US FAERS
825Incorrect route of product administrationFAERS: 1US FAERS
826Infected biteFAERS: 1US FAERS
827Infectious MononucleosisFAERS: 1US FAERS
828Inflammatory marker increasedFAERS: 1US FAERS
829Infusion Site ExtravasationFAERS: 1US FAERS
830Infusion site erythemaFAERS: 1US FAERS
831Infusion site scarFAERS: 1US FAERS
832Injection site atrophyFAERS: 1US FAERS
833Injection site calcificationFAERS: 1US FAERS
834Injection site dermatitisFAERS: 1SIDER
US FAERS
835Injection site drynessFAERS: 1US FAERS
836Injection site exfoliationFAERS: 1US FAERS
837Injection site fibrosisFAERS: 1US FAERS
838Injection site granulomaFAERS: 1US FAERS
839Injection site nerve damageFAERS: 1US FAERS
840Injection site pallorFAERS: 1US FAERS
841Injection site plaqueFAERS: 1US FAERS
842Instillation site painFAERS: 1US FAERS
843Insulin ResistanceFAERS: 119586609
28573460
CTD
US FAERS
844Insulin-like growth factor decreasedFAERS: 1US FAERS
845Insulin-requiring type 2 diabetes mellitusFAERS: 1US FAERS
846Intellectual DisabilityFAERS: 1US FAERS
847Intentional dose omissionFAERS: 1US FAERS
848Intercepted drug administration errorFAERS: 1US FAERS
849Intracranial AneurysmFAERS: 1US FAERS
850Intracranial HypotensionFAERS: 1US FAERS
851Intraocular pressure test abnormalFAERS: 1US FAERS
852Intraocular pressure testFAERS: 1US FAERS
853Investigation abnormalFAERS: 1US FAERS
854IritisFAERS: 1US FAERS
855Joint sprainFAERS: 1US FAERS
856Joint stiffnessFAERS: 1US FAERS
857Lack of injection site rotationFAERS: 1US FAERS
858Lack of spontaneous speechFAERS: 1US FAERS
859Latent Autoimmune Diabetes in AdultsFAERS: 1US FAERS
860Latex allergyFAERS: 1US FAERS
861LentigoFAERS: 1US FAERS
862LeukopeniaFAERS: 1US FAERS
863Limb operationFAERS: 1US FAERS
864LipohypertrophyFAERS: 1US FAERS
865Livedo ReticularisFAERS: 1US FAERS
866Living in residential institutionFAERS: 1US FAERS
867Local reactionFAERS: 1US FAERS
868Localised intraabdominal fluid collectionFAERS: 1US FAERS
869Loss of personal independence in daily activitiesFAERS: 1US FAERS
870Low density lipoprotein increasedFAERS: 1US FAERS
871Lupus NephritisFAERS: 1US FAERS
872LymphangitisFAERS: 1US FAERS
873MaculeFAERS: 1US FAERS
874Malabsorption from administration siteFAERS: 1US FAERS
875Malabsorption from injection siteFAERS: 1US FAERS
876Male sexual dysfunctionFAERS: 1US FAERS
877Malignant HypertensionFAERS: 1US FAERS
878Malignant neoplasm of ampulla of VaterFAERS: 1US FAERS
879MeaslesFAERS: 1US FAERS
880Medication residueFAERS: 1US FAERS
881Medication residue presentFAERS: 1US FAERS
882MeningiomaFAERS: 1US FAERS
883MeningitisFAERS: 1US FAERS
884MenopauseFAERS: 1US FAERS
885MerycismFAERS: 1US FAERS
886Metanephrine urine increasedFAERS: 1US FAERS
887Metastases to adrenalsFAERS: 1US FAERS
888Metastases to peripheral vascular systemFAERS: 1US FAERS
889Micturition frequency decreasedFAERS: 1US FAERS
890Milk AllergyFAERS: 1US FAERS
891MonoplegiaFAERS: 1US FAERS
892Mouth BreathingFAERS: 1US FAERS
893Mouth swellingFAERS: 1US FAERS
894Multiple MyelomaFAERS: 1US FAERS
895Multiple drug overdoseFAERS: 1US FAERS
896Multiple drug overdose intentionalFAERS: 1US FAERS
897Myasthenia GravisFAERS: 1US FAERS
898MyocarditisFAERS: 1US FAERS
899Myoclonic EpilepsyFAERS: 1US FAERS
900MyopiaFAERS: 1US FAERS
901NecrosisFAERS: 124534256CTD
US FAERS
902Nephrotic SyndromeFAERS: 1US FAERS
903NeurilemmomaFAERS: 1US FAERS
904Nodule on extremityFAERS: 1US FAERS
905Oral mucosal eruptionFAERS: 1US FAERS
906Oral pruritusFAERS: 1US FAERS
907OrchitisFAERS: 1US FAERS
908OsteitisFAERS: 1US FAERS
909OsteomyelitisFAERS: 1US FAERS
910OsteopeniaFAERS: 1US FAERS
911OsteoporosisFAERS: 119586609CTD
US FAERS
912Otitis MediaFAERS: 1US FAERS
913Ovarian germ cell teratoma benignFAERS: 1US FAERS
914Oxygen supplementationFAERS: 1US FAERS
915Pain of skinFAERS: 1US FAERS
916PancreatectomyFAERS: 1US FAERS
917Pancreatic FistulaFAERS: 1US FAERS
918Pancreatic calcificationFAERS: 1US FAERS
919Pancreatic carcinoma stage IIIFAERS: 1US FAERS
920Pancreatic duct dilatationFAERS: 1US FAERS
921Pancreatic duct obstructionFAERS: 1US FAERS
922Pancreatic enlargementFAERS: 1US FAERS
923PapuleFAERS: 1US FAERS
924Pararenal pseudocystFAERS: 1US FAERS
925ParotitisFAERS: 1US FAERS
926Pelvic InfectionFAERS: 1US FAERS
927Pelvic massFAERS: 1US FAERS
928Penile burning sensationFAERS: 1US FAERS
929Perforated ulcerFAERS: 1US FAERS
930PeriarthritisFAERS: 1US FAERS
931Periorbital contusionFAERS: 1US FAERS
932Peripheral artery stenosisFAERS: 1US FAERS
933Peripheral arthritisFAERS: 1US FAERS
934Peripheral nerve lesionFAERS: 1US FAERS
935PetechiaeFAERS: 1US FAERS
936PhlebitisFAERS: 1US FAERS
937Photosensitivity allergic reactionFAERS: 1US FAERS
938Physical product label issueFAERS: 1US FAERS
939Pityriasis RoseaFAERS: 1US FAERS
940PneumonitisFAERS: 1US FAERS
941Portal Vein ThrombosisFAERS: 1US FAERS
942Post procedural contusionFAERS: 1US FAERS
943Post procedural discomfortFAERS: 1US FAERS
944Post procedural nauseaFAERS: 1US FAERS
945Postoperative feverFAERS: 1US FAERS
946Postoperative infectionFAERS: 1US FAERS
947Procedural complicationFAERS: 1US FAERS
948Procedural hypertensionFAERS: 1US FAERS
949Procedural nauseaFAERS: 1US FAERS
950ProctitisFAERS: 1US FAERS
951Product administered at inappropriate siteFAERS: 1US FAERS
952Product contamination physicalFAERS: 1US FAERS
953Product dispensing errorFAERS: 1US FAERS
954Product dispensing issueFAERS: 1US FAERS
955Product expiration date issueFAERS: 1US FAERS
956Product formulation issueFAERS: 1US FAERS
957Product impurityFAERS: 1US FAERS
958Product measured potency issueFAERS: 1US FAERS
959Product reconstitution quality issueFAERS: 1US FAERS
960Product size issueFAERS: 1US FAERS
961Prostate cancer recurrentFAERS: 1US FAERS
962Prostate examination abnormalFAERS: 1US FAERS
963ProteinuriaFAERS: 1US FAERS
964Prothrombin level abnormalFAERS: 1US FAERS
965Psychiatric decompensationFAERS: 1US FAERS
966Psychiatric symptomFAERS: 1US FAERS
967Psychomotor skills impairedFAERS: 1US FAERS
968Pulmonary FibrosisFAERS: 1US FAERS
969Pulmonary congestionFAERS: 1US FAERS
970Puncture site painFAERS: 1US FAERS
971PurpuraFAERS: 1US FAERS
972Purulent dischargeFAERS: 1US FAERS
973PyelonephritisFAERS: 1US FAERS
974QuadriplegiaFAERS: 1US FAERS
975Radiotherapy to thyroidFAERS: 1US FAERS
976Rectal fissureFAERS: 1US FAERS
977Reflux gastritisFAERS: 1US FAERS
978Refractory cytopenia with unilineage dysplasiaFAERS: 1US FAERS
979Refusal of treatment by relativeFAERS: 1US FAERS
980Renal cancer recurrentFAERS: 1US FAERS
981Renal tubular disorderFAERS: 1US FAERS
982Respiratory DepressionFAERS: 1US FAERS
983Respiratory distressFAERS: 1US FAERS
984Retinal Vein OcclusionFAERS: 1US FAERS
985Retinal scarFAERS: 1US FAERS
986RhinitisFAERS: 1US FAERS
987Rubber sensitivityFAERS: 1US FAERS
988SarcopeniaFAERS: 1US FAERS
989SclerodermaFAERS: 1US FAERS
990Self-induced vomitingFAERS: 1US FAERS
991Septic ShockFAERS: 1US FAERS
992Serum SicknessFAERS: 1US FAERS
993SigmoiditisFAERS: 1US FAERS
994Single functional kidneyFAERS: 1US FAERS
995Sinus ArrhythmiaFAERS: 1US FAERS
996Sinus TachycardiaFAERS: 1US FAERS
997Sjogren's SyndromeFAERS: 1US FAERS
998Skin IndurationFAERS: 1US FAERS
999Skin discomfortFAERS: 1US FAERS
1000Skin indentationFAERS: 1US FAERS
1001Skin texture abnormalFAERS: 1US FAERS
1002Slow speechFAERS: 1US FAERS
1003Small cell lung cancer extensive stageFAERS: 1US FAERS
1004Soft tissue necrosisFAERS: 1US FAERS
1005SoliloquyFAERS: 1US FAERS
1006Somogyi phenomenonFAERS: 1US FAERS
1007Sphincter of Oddi DysfunctionFAERS: 1US FAERS
1008Spinal column injuryFAERS: 1US FAERS
1009Splenic cystFAERS: 1US FAERS
1010Splenic thrombosisFAERS: 1US FAERS
1011Splenic vein thrombosisFAERS: 1US FAERS
1012SplenitisFAERS: 1US FAERS
1013Spontaneous penile erectionFAERS: 1US FAERS
1014Squamous cell carcinoma of skinFAERS: 1US FAERS
1015Stem cell transplantFAERS: 1US FAERS
1016Stress at workFAERS: 1US FAERS
1017Subcutaneous AbscessFAERS: 1US FAERS
1018Superficial injury of eyeFAERS: 1US FAERS
1019SuperinfectionFAERS: 1US FAERS
1020Suprapubic painFAERS: 1US FAERS
1021Sweat testFAERS: 1US FAERS
1022Systemic Inflammatory Response SyndromeFAERS: 1US FAERS
1023Systemic SclerodermaFAERS: 1US FAERS
1024TachyphreniaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1025Teeth brittleFAERS: 1US FAERS
1026Temporal ArteritisFAERS: 1US FAERS
1027ThelitisFAERS: 1US FAERS
1028Therapeutic product effect decreasedFAERS: 1US FAERS
1029Therapeutic product ineffectiveFAERS: 1US FAERS
1030Therapeutic response delayedFAERS: 1US FAERS
1031ThrombocytopeniaFAERS: 1US FAERS
1032ThrombophlebitisFAERS: 1US FAERS
1033Thyroid cancer metastaticFAERS: 1US FAERS
1034Thyroid gland scan abnormalFAERS: 1US FAERS
1035Thyroid hormones decreasedFAERS: 1US FAERS
1036ThyroidectomyFAERS: 1US FAERS
1037ThyroiditisFAERS: 1US FAERS
1038Time perception alteredFAERS: 1US FAERS
1039Tongue bitingFAERS: 1US FAERS
1040Tooth ExtractionFAERS: 1US FAERS
1041Toxic Epidermal NecrolysisFAERS: 1US FAERS
1042Toxic Shock SyndromeFAERS: 1US FAERS
1043Transmission of an infectious agent via productFAERS: 1US FAERS
1044Trigeminal NeuralgiaFAERS: 1US FAERS
1045TrismusFAERS: 1US FAERS
1046Troponin increasedFAERS: 1US FAERS
1047Umbilical dischargeFAERS: 1US FAERS
1048UrethritisFAERS: 1US FAERS
1049Urinary Tract PainFAERS: 1US FAERS
1050Urinary tract infection fungalFAERS: 1US FAERS
1051Urinary tract infection viralFAERS: 1US FAERS
1052Urine bilirubin increasedFAERS: 1US FAERS
1053Urine ketone body presentFAERS: 1US FAERS
1054Vaginal DischargeFAERS: 1US FAERS
1055Vaginal ProlapseFAERS: 1US FAERS
1056Vaginal burning sensationFAERS: 1US FAERS
1057Vascular calcificationFAERS: 1US FAERS
1058Vascular purpuraFAERS: 1US FAERS
1059Venous ThrombosisFAERS: 1US FAERS
1060Ventricular arrhythmiaFAERS: 1US FAERS
1061Viral sinusitisFAERS: 1US FAERS
1062Viral upper respiratory tract infectionFAERS: 1US FAERS
1063Vulvovaginal discomfortFAERS: 1US FAERS
1064Vulvovaginal mycotic infectionFAERS: 1US FAERS
1065Vulvovaginal painFAERS: 1US FAERS
1066Waist circumference decreasedFAERS: 1US FAERS
1067Weaning failureFAERS: 1US FAERS
1068Wheelchair userFAERS: 1US FAERS
1069Wound InfectionFAERS: 1US FAERS
1070Wound dehiscenceFAERS: 1US FAERS
1071Wound infection staphylococcalFAERS: 1US FAERS
1072abdominal wall woundFAERS: 1US FAERS
1073heart rateFAERS: 1US FAERS
1074kyphosisFAERS: 1US FAERS
1075prostatitisFAERS: 1US FAERS
1076Diabetes Mellitus, Experimental19586609
19827752
19900495
CTD
1077DiabeticSIDER
1078Edema24534256CTD
1079Fatty Liver30253173CTD
1080Feeding and Eating Disorders18420740CTD
1081Hyperglycemia28573460CTD
1082Hyperplasia28213092CTD
1083Hypertrophy24534256CTD
1084InfestationSIDER
1085Ischemia19171732CTD
1086Movement Disorders18492290CTD
1087NeuroglycopeniaSIDER
1088Pancreatic Diseases24534256CTD
1089Renal Insufficiency19171732CTD
1090Vascular Diseases24534256CTD
1091Ventricular Dysfunction, Left30885636CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.